Top Searches
- News
- India News
- Coronavirus in India LIVE Updates: 100 million doses of Corbevax supplied to Centre, says Biological E Ltd
Coronavirus in India LIVE Updates: 100 million doses of Corbevax supplied to Centre, says Biological E Ltd
India logged 16,299 new coronavirus infections taking the total tally of cases to 4,42,06,996 while the active cases declined to 1,25,076, according to the Union health ministry data updated on Thursday The death toll climbed to 5,26,879 with 53 fatalities which includes four deaths reconciled by Kerala, the data updated at 8 am stated.Read Less
100 million doses of Corbevax supplied to Centre: Biological E Ltd
In a release, the city-based vaccine maker said, “Biological E. Limited has delivered 10 crore doses of Corbevax to the Government of India till now. Pan-India roll-out of Corbevax in children 12-14 years of age was initiated on March 16, 2022 and till now almost seven crore doses have been administered and 2.9 crore children have completed the two-dose vaccination regimen."
100 million doses of Corbevax supplied to Centre: Biological E Ltd
Biological E. Ltd (BE) on Thursday said it has delivered 10 crore (100 million) doses of its COVID-19 vaccine, Corbevax to the Centre so far.In a release, the city-based vaccine maker said, “Biological E. Limited has delivered 10 crore doses of Corbevax to the Government of India till now. Pan-India roll-out of Corbevax in children 12-14 years of age was initiated on March 16, 2022 and till now almost seven crore doses have been administered and 2.9 crore children have completed the two-dose vaccination regimen."
Maha records 1,877 new coronavirus cases, 5 deaths; active tally at 11,790
Maharashtra on Thursday recorded 1,877 fresh coronavirus cases, while five more patients succumbed to the infection in the state, the health department said.With these additions, the state's overall COVID-19 tally reached 80,66,243, while the death toll increased to 1,48,162, the department said in a bulletin.The state had recorded 1,847 coronavirus cases and five fatalities on Wednesday.
North Korea declares 'victory' over Covid, says Kim had fever
North Korean leader Kim Jong Un declared a "shining victory" over Covid-19 as his sister revealed he had fallen ill during the outbreak, which she blamed on Seoul, state media said Thursday. Addressing a meeting of health workers and scientists, Kim announced a "victory... in the war against the malignant pandemic disease", according to the official Korean Central News Agency.
Russia reported 25,815 new coronavirus cases on Thursday, authorities said, the highest such figure since March 23
As Covid cases rise, Delhi makes face masks mandatory in public, violators to be fined Rs 500
The active cases in India comprise 0.28 per cent of the total infections, while the national Covid-19 recovery rate was recorded at 98.53 per cent, the ministry said
Covid 19: India reported 16,299 new cases and 53 deaths in last 24 hours
53 deaths due to Covid-19 in India in last 24 hours
Thane records 212 new Covid-19 cases; active tally reaches 1,150
As many as 212 new Covid-19 cases have been detected in Maharashtra's Thane district, raising its infection tally to 7,35,817, a health official said on Thursday. With the addition of the latest cases on Wednesday, the district currently has 1,150 active Covid-19 cases, he said.
India's active Covid caseload decreases to 1.25 lakh
India reports 16,299 Covid-19 cases in 24 hours
Lucknow has reported 145 new Covid-19 cases in the past 24 hours while Uttar Pradesh reported 940 cases.
Aspen Covid vaccine lines risk going idle as J&J orders dwindle: Reuters
North Korea's Kim declares victory in battle against Covid-19: KCNA
Corbevax was first granted approval for use as heterologous booster by the drug regulator, Drugs Controller General of India (DCGI), on June 4 this year.
In heterologous boosting, a person is injected with a different vaccine from that was used for the primary dose.
all changes in regard to the administration of heterologous precautionary doses using Corbevax to those who are eligible have been made on the CoWin portal.
It will be available for those aged 18 and above after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines, the health ministry has confirmed.
